Salk scientists expand ability of stem cells to regrow any tissue type
The new technique, which allows scientists to generate both embryonic and non-embryonic tissues from cultured stem cells, is a step toward growing donor organs and replacement tissues to combat aging and diseases
When scientists talk about laboratory stem cells being totipotent or pluripotent, they mean that the cells have the potential, like an embryo, to develop into any type of tissue in the body. What totipotent stem cells can do that pluripotent ones can’t do, however, is develop into tissues that support the embryo, like the placenta. These are called extra-embryonic tissues, and are vital in development and healthy growth.
Now, scientists at the Salk Institute, in collaboration with researchers from Peking University, in China, are reporting their discovery of a chemical cocktail that enables cultured mouse and human stem cells to do just that: generate both embryonic and extra-embryonic tissues. Their technique, described in the journal Cell on April 6, 2017, could yield new insights into mammalian development that lead to better disease modeling, drug discovery and even tissue regeneration. This new technique is expected to be particularly useful for modeling early developmental processes and diseases affecting embryo implantation and placental function, possibly paving the way for improved in vitro fertilization techniques.
“During embryonic development, both the fertilized egg and its initial cells are considered totipotent, as they can give rise to all embryonic and extra-embryonic lineages. However, the capture of stem cells with such developmental potential in vitro has been a major challenge in stem cell biology,” says Salk Professor Juan Carlos Izpisua Bemonte, co–senior author of the paper and holder of Salk’s Roger Guillemin Chair. “This is the first study reporting the derivation of a stable stem cell type that shows totipotent-like bi-developmental potential towards both embryonic and extra-embryonic lineages.”
Once a mammalian egg is fertilized and begins dividing, the new cells segregate into two groups: those that will develop into the embryo and those that will develop into supportive tissues like the placenta and amniotic sac. Because this division of labor happens relatively early, researchers often can’t maintain cultured cell lines stably until cells have already passed the point where they could still become either type. The newly discovered cocktail gives stem cells the ability to stably become either type, leading the Salk team to dub them extended pluripotent stem (EPS) cells.
“The discovery of EPS cells provides a potential opportunity for developing a universal method to establish stem cells that have extended developmental potency in mammals,” says Jun Wu, a senior scientist at Salk and one of the paper’s first authors. “Importantly, the superior interspecies chimeric competency of EPS cells makes them especially valuable for studying development, evolution and human organ generation using a host animal species.”
To develop their cocktail, the Salk team, together with the team from Peking University, first screened for chemical compounds that support pluripotency. They discovered that a simple combination of four chemicals and a growth factor could stabilize the human pluripotent stem cells at a developmentally less mature state, thereby allowing them to more efficiently contribute to chimera (a mix of cells from two different species) formation in a developing mouse embryo. They also applied the same factors to mouse cells and found, surprisingly, that the newly derived mouse stem cells could not only give rise to embryonic tissue types but also differentiate into cells from the extra-embryonic lineages. Moreover, the team found that the new mouse stem cells have a superior ability to form chimeras and a single cell could give rise to an entire adult mouse, which is unprecedented in the field, according to the team.
“The superior chimeric competency of both human and mouse EPS cells is advantageous in applications such as the generation of transgenic animal models and the production of replacement organs,” adds Wu. “We are now testing to see whether human EPS cells are more efficient in chimeric contribution to pigs, whose organ size and physiology are closer to humans.” Human EPS cells, combined with the interspecies blastocyst complementation platform as reported by the same Salk team in Cell in January 2017, hold great potential for the generation of human organs in pigs to meet the rising demand for donor organs.
“We believe that the derivation of a stable stem cell line with totipotent-like features will have a broad and resounding impact on the stem cell field,” says Izpisua Belmonte.
[osd_subscribe categories=’stem-cells’ placeholder=’Email Address’ button_text=’Subscribe Now for any new posts on the topic “STEM CELLS”‘]
The Latest on: Stem cells
via Google News
The Latest on: Stem cells
- “Killer cells” and conflicts at California’s stem cell agencyon May 25, 2022 at 11:30 am
Wrapped up in the case are the tangled complexities of conflicts of interest at California's voter approved stem cell agency.
- Golden Meditech Stem Cells Responds to Unfounded Accusationson May 25, 2022 at 8:17 am
HONG KONG, May 25, 2022 /PRNewswire/ -- On May 25, 2022, Golden Meditech Stem Cells (BVI) Company Limited (the "Company"), would like to respond to the accusations made against the Company in ...
- 'I want to regenerate an entire leg by 2030' | Doctor's synthetic artificial stem cells research could revolutionize healingon May 24, 2022 at 1:25 pm
The next project we're working on is SASC shoulder, a SASC shoulder where we try to regenerate the rotator cuff, especially for people who have, say, a partial tear that's painful that that means they ...
- Stem Cell Cloning Experts Unraveling Cystic Fibrosison May 24, 2022 at 7:08 am
Two nationally recognized experts in cloning and stem cell science from the University of Houston are taking the first step toward limiting the consequences of chronic inflammatio ...
- The American Academy of Stem Cell Physicians Adds Three Workshops to the June 17-19, 2022 Conferenceon May 24, 2022 at 7:03 am
The hands-on workshops will be on intra discal injections, bone marrow aspiration and muscular skeleton ultrasound techniques. Featured Image for The American Academy of Stem Cell Physicians Featured ...
- Induced Pluripotent Stem Cells Market Overview, Growth Factors, Demand, Trends and Forecast to 2027on May 24, 2022 at 5:55 am
The MarketWatch News Department was not involved in the creation of this content. May 23, 2022 (Market Insight Reports) -- Induced Pluripotent Stem Cells market report gives attention to market ...
- How one of the X chromosomes in female embryonic stem cells is silencedon May 20, 2022 at 6:33 am
In most mammals, females have two X chromosomes and males have one X and one Y chromosome in each of their cells. To avoid a double dose of X-linked genes in females, one of the Xs is silenced early ...
- Off-The-Shelf, Targeted Engineered Stem Cell Therapy for Glioblastoma Keeps Mice Aliveon May 20, 2022 at 5:00 am
Researchers hope to start Phase I trials with the encapsulated engineered stem-cell therapeutic within two years.
- “Off the Shelf” Engineered Stem Cells Created To Treat Aggressive Brain Canceron May 19, 2022 at 2:02 am
Investigators uncovered a diagnostic method to identify receptors on cancer cells in the blood, then engineered a cell-based therapy to target and kill tumor cells in the brain, paving the way to ...
via Bing News